PortViewPortView
Keryx Biopharmaceuticals logo

Keryx Biopharmaceuticals (KERX) Stock Analysis

NASDAQHealthcareBiotechnology

$3.36+0.00%
52-week range$3.36
$2.47$5.98

What Keryx Biopharmaceuticals does

Keryx Biopharmaceuticals, Inc. (NASDAQ: KERX) is a Biotechnology company in the Healthcare sector.

Key metrics

Market cap
$0
P/E (TTM)
-4.43
EPS (TTM)
$-0.76
Beta
1.82
Dividend yield
0.00%
Revenue / share
$0.53
50-day avg
$3.06
200-day avg
$3.91
52-week high
$5.98
52-week low
$2.47

ETFs linked to KERX

Broad-market and Healthcare sector ETFs an investor holding Keryx Biopharmaceuticals is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how KERX fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze KERX in PortView →

Similar companies

Frequently asked questions

What is the ticker symbol for Keryx Biopharmaceuticals?
Keryx Biopharmaceuticals trades under the ticker KERX on NASDAQ.
Which exchange is KERX listed on?
KERX is listed on NASDAQ.
What sector does Keryx Biopharmaceuticals operate in?
Keryx Biopharmaceuticals is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze KERX in a portfolio?
PortView shows KERX's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.